\-\ Texto\\:\\ \ \(0\)\
\-\ his\\ temp\\ on\\ admission\\ was\\ 101\\.2f\\.\ \(0\)\
\-\ on\\ pe\\,\\ he\\ had\\ coarse\\ breath\\ sounds\\ bilaterally\\ with\\ l\\>r\\ and\\ decreased\\ breath\\ sounds\\ on\\ the\\ l\\.\ \(0\)\
\-\ cbc\\ showed\\ a\\ wbc\\ count\\ of\\ 37\\,000\\ with\\ neutrophil\\ predominance\\.\ \(0\)\
\-\ treated\\ with\\ antibiotics\\ and\\ scheduled\\ for\\ follow\\ up\\ cxr\\ in\\ 4\\-6\\ weeks\\.\ \(0\)\
\-\ pa\\/lateral\\ of\\ chest\\ showed\\ a\\ moderate\\ sized\\ left\\ pleural\\ effusion\\ with\\ evidence\\ of\\ left\\ lower\\ lobe\\ consolidation\\ obscuring\\ the\\ left\\ hemidiaphragm\\,\\ concerning\\ for\\ pneumonia\\.\\ \\ \ \(0\)\
\-\ us\\ of\\ chest\\ showed\\ a\\ small\\ left\\ pleural\\ effusion\\ without\\ evidence\\ of\\ loculation\\.\ \(0\)\
\-\ left\\ lower\\ lobe\\ bacterial\\ pneumonia\\,\\ pleural\\ effusion\ \(0\)\
\-\ 1\\)\\ pneumonia\\:\\ most\\ likely\\ provided\\ the\\ clinical\\ history\\ and\\ lack\\ of\\ cardiac\\/oncologic\\ risk\\ factors\\.\\ \\ \ \(0\)\
\-\ 2\\)\\ atelectasis\\:\\ often\\ interstitial\\ pattern\\ with\\ linear\\ strands\\ or\\ change\\ in\\ size\\ of\\ affected\\ lung\\ \ \(0\)\
\-\ 3\\)\\ effusion\\ other\\ than\\ parapneumonic\\:\\ pleural\\ effusions\\ can\\ arise\\ due\\ to\\ numerous\\ causes\\ other\\ than\\ parapneumonic\\ and\\ can\\ obscure\\ healthy\\ lung\\ \ \(0\)\
\-\ 4\\)\\ pulmonary\\ edema\\ \ \(0\)\
\-\ 5\\)\\ tb\\:\\ both\\ tb\\ and\\ pulmonary\\ edema\\ may\\ involve\\ the\\ interstitium\\ and\\ the\\ alveoli\\ concurrently\\ \ \(0\)\
\-\ 6\\)\\ tumor\\:\\ often\\ involves\\ atelectasis\\ and\\ pleural\\ fluid\\.\ \(0\)\
\-\ 2yo\\ 9mo\\ boy\\ with\\ a\\ significant\\ past\\ medical\\ history\\ of\\ asthma\\.\\ \\ presents\\ now\\ with\\ a\\ 1\\ week\\ history\\ of\\ productive\\ cough\\,\\ shortness\\ of\\ air\\,\\ fever\\,\\ and\\ oxygen\\ desaturation\\ to\\ 85\\%\\.\ \(0\)\
\-\ this\\ patient\\ is\\ classic\\ for\\ bacterial\\ pna\\ with\\ fever\\,\\ soa\\,\\ productive\\ cough\\,\\ oxygen\\ desaturation\\,\\ elevated\\ wbc\\,\\ and\\ positive\\ cultures\\ combined\\ with\\ the\\ radiographic\\ findings\\ on\\ cxr\\ and\\ confirmed\\ non\\-loculated\\ pleural\\ effusion\\ by\\ us\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pleural\\:\\ 0\\.3169276370814989\ \(0\)\
\-\ effusion\\:\\ 0\\.2605226540433325\ \(0\)\
\-\ parapneumonic\\:\\ 0\\.20737253521334156\ \(0\)\
\-\ desaturation\\:\\ 0\\.18742269250090451\ \(0\)\
\-\ pneumonia\\:\\ 0\\.1661487953559087\ \(0\)\
\-\ productive\\:\\ 0\\.15134906581779034\ \(0\)\
\-\ and\\:\\ 0\\.1449916177745488\ \(0\)\
\-\ oxygen\\:\\ 0\\.14427174648521054\ \(0\)\
\-\ showed\\:\\ 0\\.1402086493208039\ \(0\)\
\-\ of\\:\\ 0\\.13731381060660863\ \(0\)\
\-\ bacterial\\:\\ 0\\.13132923391710077\ \(0\)\
\-\ atelectasis\\:\\ 0\\.12496093146931433\ \(0\)\
\-\ tb\\:\\ 0\\.12496093146931433\ \(0\)\
\-\ with\\:\\ 0\\.12365627001815342\ \(0\)\
\-\ left\\:\\ 0\\.11967755505568103\ \(0\)\
\-\ cxr\\:\\ 0\\.11226487641303347\ \(0\)\
\-\ loculation\\:\\ 0\\.11221238795106996\ \(0\)\
\-\ 9mo\\:\\ 0\\.11221238795106996\ \(0\)\
\-\ soa\\:\\ 0\\.11221238795106996\ \(0\)\
\-\ us\\:\\ 0\\.11162915155372358\ \(0\)\
\-\ sounds\\:\\ 0\\.10834412131713751\ \(0\)\
\-\ cough\\:\\ 0\\.10477247211335379\ \(0\)\
\-\ strands\\:\\ 0\\.10368626760667078\ \(0\)\
\-\ breath\\:\\ 0\\.1028545259586319\ \(0\)\
\-\ 2yo\\:\\ 0\\.10094146992741798\ \(0\)\
\-\ pna\\:\\ 0\\.10094146992741798\ \(0\)\
\-\ wbc\\:\\ 0\\.09918807439060259\ \(0\)\
\-\ concurrently\\:\\ 0\\.09680266238056465\ \(0\)\
\-\ fever\\:\\ 0\\.09514831886909744\ \(0\)\
\-\ neutrophil\\:\\ 0\\.09371134625045226\ \(0\)\
\-\ alveoli\\:\\ 0\\.09371134625045226\ \(0\)\
\-\ often\\:\\ 0\\.09156799108086634\ \(0\)\
\-\ obscure\\:\\ 0\\.09124297799174791\ \(0\)\
\-\ obscuring\\:\\ 0\\.08742788890490953\ \(0\)\
\-\ interstitium\\:\\ 0\\.08742788890490953\ \(0\)\
\-\ pulmonary\\:\\ 0\\.08554010321736522\ \(0\)\
\-\ lung\\:\\ 0\\.08536685473321201\ \(0\)\
\-\ on\\:\\ 0\\.08476661368262392\ \(0\)\
\-\ the\\:\\ 0\\.0840052134220328\ \(0\)\
\-\ edema\\:\\ 0\\.08369833862387216\ \(0\)\
\-\ lobe\\:\\ 0\\.08109828064934026\ \(0\)\
\-\ history\\:\\ 0\\.08042362507043811\ \(0\)\
\-\ evidence\\:\\ 0\\.07965384506942524\ \(0\)\
\-\ than\\:\\ 0\\.0795514111265225\ \(0\)\
\-\ predominance\\:\\ 0\\.07772939696923947\ \(0\)\
\-\ chest\\:\\ 0\\.07407544900919581\ \(0\)\
\-\ coarse\\:\\ 0\\.0739143078824011\ \(0\)\
\-\ can\\:\\ 0\\.07364288959156892\ \(0\)\
\-\ hemidiaphragm\\:\\ 0\\.073120445895364\ \(0\)\
\-\ other\\:\\ 0\\.07287775091272242\ \(0\)\
\-\ lower\\:\\ 0\\.0717108781543514\ \(0\)\
\-\ sized\\:\\ 0\\.07167164488354463\ \(0\)\
\-\ asthma\\:\\ 0\\.0699723139989331\ \(0\)\
\-\ temp\\:\\ 0\\.06958178622907409\ \(0\)\
\-\ combined\\:\\ 0\\.06958178622907409\ \(0\)\
\-\ concerning\\:\\ 0\\.06730713207684341\ \(0\)\
\-\ cultures\\:\\ 0\\.06609126983965781\ \(0\)\
\-\ effusions\\:\\ 0\\.06566461695855039\ \(0\)\
\-\ scheduled\\:\\ 0\\.06511783398398296\ \(0\)\
\-\ consolidation\\:\\ 0\\.0648532949380084\ \(0\)\
\-\ 85\\:\\ 0\\.06472312873351362\ \(0\)\
\-\ arise\\:\\ 0\\.06421581594673102\ \(0\)\
\-\ for\\:\\ 0\\.06380128280283448\ \(0\)\
\-\ interstitial\\:\\ 0\\.0636097528982061\ \(0\)\
\-\ involve\\:\\ 0\\.06174744768802668\ \(0\)\
\-\ involves\\:\\ 0\\.06105566588467492\ \(0\)\
\-\ lack\\:\\ 0\\.06004155998474235\ \(0\)\
\-\ healthy\\:\\ 0\\.05952173933215623\ \(0\)\
\-\ factors\\:\\ 0\\.05935323544315169\ \(0\)\
\-\ numerous\\:\\ 0\\.059269841282783044\ \(0\)\
\-\ admission\\:\\ 0\\.058543693923667886\ \(0\)\
\-\ cbc\\:\\ 0\\.058543693923667886\ \(0\)\
\-\ pe\\:\\ 0\\.05800713446391996\ \(0\)\
\-\ count\\:\\ 0\\.05793235860118832\ \(0\)\
\-\ affected\\:\\ 0\\.05771072032485867\ \(0\)\
\-\ provided\\:\\ 0\\.05756514949525863\ \(0\)\
\-\ linear\\:\\ 0\\.05652504360353024\ \(0\)\
\-\ shortness\\:\\ 0\\.05626191931303931\ \(0\)\
\-\ change\\:\\ 0\\.053170603182926934\ \(0\)\
\-\ causes\\:\\ 0\\.05301967378581069\ \(0\)\
\-\ moderate\\:\\ 0\\.052674544369060085\ \(0\)\
\-\ classic\\:\\ 0\\.05248158995696574\ \(0\)\
\-\ pattern\\:\\ 0\\.052386236056676895\ \(0\)\
\-\ radiographic\\:\\ 0\\.0520582008422611\ \(0\)\
\-\ confirmed\\:\\ 0\\.05173868699399069\ \(0\)\
\-\ antibiotics\\:\\ 0\\.051693712203342165\ \(0\)\
\-\ risk\\:\\ 0\\.050135660164952585\ \(0\)\
\-\ now\\:\\ 0\\.048166280827689416\ \(0\)\
\-\ boy\\:\\ 0\\.04799892325913106\ \(0\)\
\-\ elevated\\:\\ 0\\.04783381216880722\ \(0\)\
\-\ size\\:\\ 0\\.04751009370879225\ \(0\)\
\-\ week\\:\\ 0\\.047194676643753326\ \(0\)\
\-\ bilaterally\\:\\ 0\\.04679636615200299\ \(0\)\
\-\ positive\\:\\ 0\\.04623648210948191\ \(0\)\
\-\ air\\:\\ 0\\.045895566296632606\ \(0\)\
\-\ past\\:\\ 0\\.04567342768100217\ \(0\)\
\-\ medical\\:\\ 0\\.04459396699118889\ \(0\)\
\-\ clinical\\:\\ 0\\.04446857761244722\ \(0\)\
\-\ treated\\:\\ 0\\.04369500462195388\ \(0\)\
\-\ decreased\\:\\ 0\\.043462911103567765\ \(0\)\
\-\ his\\:\\ 0\\.0425546241840572\ \(0\)\
\-\ weeks\\:\\ 0\\.04205248950366085\ \(0\)\
\-\ likely\\:\\ 0\\.04193009454815925\ \(0\)\
\-\ he\\:\\ 0\\.0415503548232645\ \(0\)\
\-\ fluid\\:\\ 0\\.040512908806460274\ \(0\)\
\-\ significant\\:\\ 0\\.040512908806460274\ \(0\)\
\-\ due\\:\\ 0\\.04033333493782254\ \(0\)\
\-\ both\\:\\ 0\\.03912859335013697\ \(0\)\
\-\ follow\\:\\ 0\\.03782613289299152\ \(0\)\
\-\ without\\:\\ 0\\.03701048065838022\ \(0\)\
\-\ tumor\\:\\ 0\\.0367014380727996\ \(0\)\
\-\ most\\:\\ 0\\.036517057445443514\ \(0\)\
\-\ small\\:\\ 0\\.03619452739096919\ \(0\)\
\-\ may\\:\\ 0\\.03531027194386366\ \(0\)\
\-\ to\\:\\ 0\\.03508324921339044\ \(0\)\
\-\ had\\:\\ 0\\.03495980403349387\ \(0\)\
\-\ in\\:\\ 0\\.03491056953342204\ \(0\)\
\-\ up\\:\\ 0\\.03470899551689465\ \(0\)\
\-\ findings\\:\\ 0\\.03463025346402721\ \(0\)\
\-\ presents\\:\\ 0\\.03375397280502874\ \(0\)\
\-\ by\\:\\ 0\\.029796998827250145\ \(0\)\
\-\ was\\:\\ 0\\.02445391152197555\ \(0\)\
\-\ or\\:\\ 0\\.024409867184545245\ \(0\)\
\-\ this\\:\\ 0\\.024110661896949426\ \(0\)\
\-\ patient\\:\\ 0\\.022821818815957136\ \(0\)\
\-\ is\\:\\ 0\\.019215723287690775\ \(0\)\
